Daly James Minsider trades

In SEC Form 4 filings, Daly James M is listed as Director of Cytokinetics Inc (CYTK) and Director of Halozyme Therapeutics, Inc. (HALO). Daly James M reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Oct 20.

Companies and roles

Company	Role	Transactions	Last filed
CYTKCytokinetics Inc	Director	1	Oct 20
HALOHalozyme Therapeutics, Inc.	Director	2	Oct 2

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-10-02

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
CYTKCytokinetics Inc	Oct 16	Oct 20	A	195	$63.92	$12,464	3,585	No	Form 4
HALOHalozyme Therapeutics, Inc.	Oct 1	Oct 2	A	1,169	$0.00	$0	1,169	No	Form 4
HALOHalozyme Therapeutics, Inc.	Oct 1	Oct 2	A · derivative	1,775	$106.94	$189,819	1,775	No	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.